Spondylocarpotarsal synostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3275OMIM:272460Q76.4
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spondylocarpotarsal synostosis syndrome (SCT syndrome), also known as spondylocarpotarsal synostosis or congenital scoliosis with unilateral unsegmented bar, is a rare skeletal disorder characterized by the fusion (synostosis) of the vertebrae (spondylo-), carpal (wrist), and tarsal (ankle) bones. The condition primarily affects the skeletal system, leading to progressive vertebral fusions that result in a short trunk and disproportionate short stature. Vertebral block fusions, particularly involving the thoracic and lumbar spine, are a hallmark feature and can produce a characteristic unilateral unsegmented bar appearance on imaging. Additional skeletal findings include lordosis, scoliosis, and fusions of the carpal and tarsal bones. Affected individuals may also exhibit facial dysmorphism, including a broad nasal bridge and a round face, as well as dental anomalies and mild hearing loss in some cases. The condition is caused by biallelic pathogenic variants in the FLNB gene (filamin B), which encodes a cytoskeletal protein important for vertebral segmentation and skeletal development. The FLNB gene is also associated with other skeletal dysplasias, including Larsen syndrome and atelosteogenesis types I and III, though those conditions follow different inheritance patterns. Spondylocarpotarsal synostosis syndrome follows an autosomal recessive inheritance pattern. Onset is typically recognized in childhood, often when short stature or spinal abnormalities become clinically apparent, though vertebral fusions may be present from birth. There is currently no cure for spondylocarpotarsal synostosis syndrome. Management is supportive and multidisciplinary, focusing on orthopedic monitoring and intervention for progressive spinal deformities, which may include bracing or surgical correction in severe cases. Respiratory function should be monitored, as restrictive lung disease can develop secondary to thoracic vertebral fusions. Hearing assessments and dental evaluations are also recommended. Genetic counseling is important for affected families to understand recurrence risks.

Also known as:

Clinical phenotype terms— hover any for plain English:

Intervertebral space narrowingHP:0002945Vertebral fusionHP:0002948Carpal synostosisHP:0009702Delayed ossification of carpal bonesHP:0001216
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Spondylocarpotarsal synostosis.

View clinical trials →

No actively recruiting trials found for Spondylocarpotarsal synostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Spondylocarpotarsal synostosis community →

Specialists

15 foundView all specialists →
SM
Sajid Malik
HICKSVILLE, NY
Specialist
1 Spondylocarpotarsal synostosis publication
NS
Nazish Shakoor
Specialist
1 Spondylocarpotarsal synostosis publication
AB
Anisa Bibi
Specialist
1 Spondylocarpotarsal synostosis publication
AQ
Asma Saleem Qazi
Specialist
1 Spondylocarpotarsal synostosis publication
RS
Rida Fatima Saeed
Specialist
1 Spondylocarpotarsal synostosis publication
AN
Aqeela Nawaz
Specialist
1 Spondylocarpotarsal synostosis publication
SM
Sara Mumtaz
Specialist
1 Spondylocarpotarsal synostosis publication
JL
Joonhwan Lee
Specialist
1 Spondylocarpotarsal synostosis publication
HS
Hamna Shahid
Specialist
1 Spondylocarpotarsal synostosis publication
EL
Eunyoung Lee
Specialist
1 Spondylocarpotarsal synostosis publication
RR
R Ramos-Mejía
Specialist
1 Spondylocarpotarsal synostosis publication
MP
M Del Pino
Specialist
1 Spondylocarpotarsal synostosis publication
BR
Byungju Ryu
Specialist
1 Spondylocarpotarsal synostosis publication
YK
Yunhee Kim
PORTLAND, OR
Specialist
1 Spondylocarpotarsal synostosis publication
MA
M Aza-Carmona
Specialist
1 Spondylocarpotarsal synostosis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spondylocarpotarsal synostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spondylocarpotarsal synostosisForum →

No community posts yet. Be the first to share your experience with Spondylocarpotarsal synostosis.

Start the conversation →

Latest news about Spondylocarpotarsal synostosis

No recent news articles for Spondylocarpotarsal synostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Spondylocarpotarsal synostosis

What is Spondylocarpotarsal synostosis?

Spondylocarpotarsal synostosis syndrome (SCT syndrome), also known as spondylocarpotarsal synostosis or congenital scoliosis with unilateral unsegmented bar, is a rare skeletal disorder characterized by the fusion (synostosis) of the vertebrae (spondylo-), carpal (wrist), and tarsal (ankle) bones. The condition primarily affects the skeletal system, leading to progressive vertebral fusions that result in a short trunk and disproportionate short stature. Vertebral block fusions, particularly involving the thoracic and lumbar spine, are a hallmark feature and can produce a characteristic unilate

How is Spondylocarpotarsal synostosis inherited?

Spondylocarpotarsal synostosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Spondylocarpotarsal synostosis typically begin?

Typical onset of Spondylocarpotarsal synostosis is childhood. Age of onset can vary across affected individuals.

Which specialists treat Spondylocarpotarsal synostosis?

15 specialists and care centers treating Spondylocarpotarsal synostosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.